4
Changes in Ownership
Acrivon Therapeutics, Inc. Filed Acc 0001140361-23-028539
Chief Operating Officer acquired 9,225 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Devroe Eric · Chief Operating Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-06-05 | Exercise or conversion : show line 1 in the form | +9,225 | $1.04 | $9,594 | 62,883 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-06-05 | Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) | −9,225 | 96,615 | D |
Loading xslF345X04/form4.xml…